110 related articles for article (PubMed ID: 11146252)
21. Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella spp. in a Singapore hospital: clinical spectrum.
Chlebicki MP; Oh HM
Ann Acad Med Singap; 2004 May; 33(3):302-6. PubMed ID: 15175768
[TBL] [Abstract][Full Text] [Related]
22. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of flomoxef against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Korea.
Jung Y; Lee SS; Song W; Kim HS; Uh Y
Diagn Microbiol Infect Dis; 2019 May; 94(1):88-92. PubMed ID: 30658867
[TBL] [Abstract][Full Text] [Related]
24. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
Akyar I
Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
[TBL] [Abstract][Full Text] [Related]
25. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
Martínez JA; Aguilar J; Almela M; Marco F; Soriano A; López F; Balasso V; Pozo L; Mensa J
J Antimicrob Chemother; 2006 Nov; 58(5):1082-5. PubMed ID: 16950822
[TBL] [Abstract][Full Text] [Related]
26. First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.
Colodner R; Samra Z; Keller N; Sprecher H; Block C; Peled N; Lazarovitch T; Bardenstein R; Schwartz-Harari O; Carmeli Y;
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):201-5. PubMed ID: 17258084
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli.
Oliver A; Weigel LM; Rasheed JK; McGowan JE; Raney P; Tenover FC
Antimicrob Agents Chemother; 2002 Dec; 46(12):3829-36. PubMed ID: 12435684
[TBL] [Abstract][Full Text] [Related]
28. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
29. Variation in approach to ESBL Enterobacteriaceae among infection control practitioners: results of an Ontario-wide survey.
Muller M; McGeer A
Can Commun Dis Rep; 2002 Aug; 28(15):121-4. PubMed ID: 12168403
[No Abstract] [Full Text] [Related]
30. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
31. ESBL Detection: Comparison of a Commercially Available Chromogenic Test for Third Generation Cephalosporine Resistance and Automated Susceptibility Testing in Enterobactericeae.
El-Jade MR; Parcina M; Schmithausen RM; Stein C; Meilaender A; Hoerauf A; Molitor E; Bekeredjian-Ding I
PLoS One; 2016; 11(8):e0160203. PubMed ID: 27494134
[TBL] [Abstract][Full Text] [Related]
32. Activity of amoxycillin/clavulanate against beta-lactamase-producing Escherichia coli and Klebsiella spp.
Roy C; Segura C; Torrellas A; Reig R; Teruel D; Hermida M
J Antimicrob Chemother; 1989 Nov; 24 Suppl B():41-7. PubMed ID: 2691485
[TBL] [Abstract][Full Text] [Related]
33. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
34. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
35. High incidence of extended-spectrum beta-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method.
Sorlózano A; Gutiérrez J; Palanca M; Soto MJ; Piédrola G
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):131-4. PubMed ID: 15474323
[TBL] [Abstract][Full Text] [Related]
36. An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum beta-lactamases.
Brenwald NP; Jevons G; Andrews JM; Xiong JH; Hawkey PM; Wise R
J Antimicrob Chemother; 2003 Jan; 51(1):195-6. PubMed ID: 12493817
[No Abstract] [Full Text] [Related]
37. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
Basak S; Mallick SK; Bose S
J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh.
Rahman MM; Haq JA; Hossain MA; Sultana R; Islam F; Islam AH
Int J Antimicrob Agents; 2004 Nov; 24(5):508-10. PubMed ID: 15519486
[TBL] [Abstract][Full Text] [Related]
39. Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students.
Chirindze LM; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Sundsfjord A; Essack SY; Simonsen GS
BMC Infect Dis; 2018 May; 18(1):244. PubMed ID: 29843632
[TBL] [Abstract][Full Text] [Related]
40. Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Jung HI; Song JS; Jeong BC; Kim SJ; Lee SH
Lett Appl Microbiol; 2004; 39(1):41-7. PubMed ID: 15189286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
